Floarea – Adriana Cojocaru | Pediatric Psychiatry | Best Researcher Award

Posted on by Molecular Biologist

Assist Prof Dr. Floarea – Adriana Cojocaru | Pediatric Psychiatry | Best Researcher Award 

Assist. Professor Doctorate, “Victor Babes” University of Medicine and Pharmacy Timisoara, Romania.

Floarea-Adriana Cojocaru is an accomplished University Assistant at “Victor Babes” University of Medicine and Pharmacy Timisoara and a Pediatric Psychiatry MD at “Louis Ţurcanu” Emergency Clinical Hospital for Children. With over a decade of experience in pediatric psychiatry, she is also the President of the Romanian Society of Child and Adolescent Neurology and Psychiatry (RSCANP) and the Editor-in-Chief of the Romanian Journal of Child and Adolescent Neurology and Psychiatry.

Profile

ORCID

Education 

Floarea-Adriana holds a Bachelor’s degree in General Medicine from “Victor Babes” University of Medicine and Pharmacy Timisoara (2010). She has further specialized in Pediatric Psychiatry, completing her residency at “Louis Ţurcanu” Emergency Clinical Hospital for Children, and is currently pursuing a Ph.D. in Pediatric Psychiatry, focusing on personalized therapies in child and adolescent psychotic disorders.

Professional Experience 

Since 2011, Adriana has been a pediatric psychiatrist at “Louis Ţurcanu” Emergency Clinical Hospital for Children, where she currently serves as the Pediatric Psychiatry Primary. She has also been an integral part of the Romanian Society of Child and Adolescent Neurology and Psychiatry, holding key positions such as General Secretary and Editor-in-Chief. In 2023, she became President of the society, reflecting her leadership in pediatric mental health.

Research Interests 

Adriana’s research focuses on pediatric psychiatry, particularly in the neuroimaging and pharmacogenetic aspects of child and adolescent psychotic disorders. She is passionate about implementing personalized therapeutic approaches for young patients, combining clinical practice with cutting-edge research.

Awards and Recognitions 

Adriana has been acknowledged for her contributions to pediatric psychiatry through various positions and recognitions. Her leadership as the President of RSCANP and her role as Editor-in-Chief of the Romanian Journal of Child and Adolescent Neurology and Psychiatry highlight her impact in the field.

Publications 

Adriana has contributed to several peer-reviewed journals in pediatric psychiatry, focusing on child and adolescent mental health. Here are selected

Cognitive-behavioral interventions for children with anxiety disorders

  • Journal: Romanian Journal of Child and Adolescent Neurology and Psychiatry (2021)
  • Cited by: 15 articles
  • Overview: This paper explores the use of cognitive-behavioral therapy (CBT) techniques for treating anxiety disorders in children. The focus is on evidence-based approaches, such as exposure therapy, cognitive restructuring, and relaxation training. The authors emphasize how these interventions can be adapted for children, taking into account developmental stages, and the need for family involvement in treatment. The research highlights that CBT is among the most effective interventions for pediatric anxiety disorders, showing significant improvement in anxiety symptoms compared to other therapeutic approaches.
  • Key Findings:
    • High success rates of CBT in reducing symptoms of generalized anxiety disorder, social anxiety, and separation anxiety in children.
    • The importance of integrating parental involvement in the therapeutic process.
    • Benefits of customizing therapy techniques to suit the developmental needs of younger children.
  • Conclusion: CBT remains the gold standard for treating childhood anxiety disorders, particularly when interventions are personalized for individual needs.

Personalized approaches in treating pediatric psychosis

    • Journal: Journal of Pediatric Psychiatry (2020)
    • Cited by: 12 articles
    • Overview: This paper discusses novel, personalized treatment strategies for pediatric psychosis, emphasizing the heterogeneity of the disorder and the need for individualized care. The authors advocate for a comprehensive assessment of biological, psychological, and social factors before creating treatment plans. Pharmacotherapy, cognitive-behavioral therapy, and family-based interventions are examined for their effectiveness in treating early-onset psychosis.
    • Key Findings:
      • Early intervention is critical in improving long-term outcomes for children with psychosis.
      • The paper highlights the potential benefits of pharmacogenetic testing to personalize medication choices.
      • Family therapy is crucial in managing the impact of psychosis on family dynamics and support systems.
    • Conclusion: Personalized treatment approaches, combining pharmacological, therapeutic, and family support interventions, are more effective in managing pediatric psychosis than generalized treatments.

Conclusion

Dr. Floarea-Adriana Cojocaru is a strong candidate for the Best Researcher Award due to her outstanding leadership roles, innovative PhD research, and extensive contributions to pediatric psychiatry and psychotherapy. Her academic, clinical, and editorial work collectively illustrate her significant impact on the mental health field, especially for children and adolescents. A focus on expanding international research collaborations and increasing her personal publications in high-impact journals will further enhance her candidacy for future awards.

Younes Bakri | Clinical applications | Outstanding Scientist Award

Posted on by Molecular Biologist

Dr. Younes Bakri | Clinical applications | Outstanding Scientist Award 

Independent Scientist, Independent Scientist, Jordan.

Dr. Younes N. Bakri is a highly regarded independent scientist with expertise in gynecologic oncology and obstetrics & gynecology. With extensive experience spanning across the USA, Jordan, and internationally, he has contributed significantly to both clinical practice and academic research. Dr. Bakri is also recognized for his medical inventions, including the widely-used Bakri Balloon, aimed at improving maternal health outcomes.

Profile

Google Scholar

Education

Dr. Bakri earned his medical degree from UNRWA Medical School, Alexandria, Egypt, in 1971. He later completed his residency in internal medicine and went on to specialize in gynecologic oncology, with further training and fellowships at prestigious institutions like Thomas Jefferson University Hospital in Philadelphia, USA.

Experience

Dr. Bakri’s professional journey includes key leadership roles such as Director of Gynecologic Oncology at institutions like King Faisal Specialist Hospital & Research Center in Saudi Arabia, Mercer University School of Medicine, and West Virginia Medical School. He has worked as a consultant and full professor across the USA and Jordan, with notable contributions to improving maternal health and cancer care systems globally.

Research Interest

Dr. Bakri’s research interests focus on gynecologic oncology, postpartum hemorrhage management, and minimally invasive surgeries. He has actively contributed to advancing medical technologies and techniques in these areas, with a passion for improving patient outcomes through innovation and research.

Awards

Dr. Bakri has received numerous accolades throughout his career, including the prestigious Honoris Causa Professor for Obstetric Emergencies from the University of Guanajuato, Mexico, and multiple Teacher of the Year awards at King Faisal Specialist Hospital & Research Center. He has also been recognized for his outstanding photography skills, securing awards in both Middle East and US contests.

Publications

Dr. Bakri has contributed to many peer-reviewed journals and medical investigations, including his notable publications on gynecologic oncology and innovative surgical techniques.

  • Bakri Y, Amri A, Abdul Jabbar F. Tamponade Balloon for Obstetrical Bleeding. International Journal of Gynecology and Obstetrics, 2001; 74:139-144. Cited by 500+ articles
  • Bakri Y, Sundin T, Mansi M. Liver Metastases of Choriocarcinoma. Gynecologic Oncology, 1993; 48:110-113. Cited by 200+ articles
  • Bakri Y, Akhtar M. Malignant Ovarian Germ Cell Tumors. Acta Oncologica, 1999; 38:455-460. Cited by 300+ articles

Conclusion

Dr. Younes N. Bakri’s extensive career, pioneering innovations, global medical contributions, and strong academic background make him a highly suitable candidate for the Research for Outstanding Scientist Award. His leadership in gynecologic oncology, especially with groundbreaking inventions like the Bakri Balloon, has had a transformative impact on maternal and cancer care. While there is room to increase the volume of recent research, his lifetime contributions to the field, global outreach, and sustained clinical influence position him as a strong contender for the award.

Daniel Guerreiro Diniz | Neuroscience | Best Researcher Award

Posted on by Molecular Biologist

Dr. Daniel Guerreiro Diniz | Neuroscience | Best Researcher Award

Postdoctoral research, Federal University of Pará, Brazil.

Daniel Guerreiro Diniz is a dedicated postdoctoral researcher at the Federal University of Pará and João de Barros Barreto University Hospital. He specializes in Neuroscience, Fish Parasitology, Neuroecology of migratory birds, and Tropical Diseases. With a background in Biological Sciences, Daniel’s work delves into the intricate mechanisms of neuroplasticity, behavior, and infection responses in both animals and humans.

Profile

Scopus

Education

Daniel holds a degree in Biological Sciences from the Federal University of Pará (2008). He pursued a Master’s and Ph.D. in Neuroscience and Cell Biology at the same institution (2010 and 2014), followed by a prestigious Post-Doctoral Fellowship at the University of Oxford (CNPq/PDE – 2015).

Experience

Daniel has substantial research experience in both national and international settings, focusing on Neuroecology, the effects of environment and infections on the nervous system, and translational neuroscience. His current research projects span viral infections in migratory species, neuroinflammation, and behavioral neuroscience.

Research Interests

Daniel’s research interests include Neuroplasticity, Cognitive Decline, Environmental Neuroscience, and Translational Neuroscience. He explores how environmental factors, viral infections, and aging influence brain behavior, particularly in species such as migratory birds, bats, and mice.

Awards

Daniel is the recipient of a Research Productivity Scholarship (CNPq – PQ-2) for the period 2022-2025. His contributions to the field have been recognized nationally and internationally, emphasizing his role as a leading figure in neuroscience research in the Amazon region.

Publications

📝 Daniel has contributed to numerous high-impact publications, with notable works including:

  • 2024 – Unraveling the Influence of Litter Size, Maternal Care, Exercise, and Aging on Neurobehavioral Plasticity and Dentate Gyrus Microglia Dynamics in Male Rats
    • Journal: Brain Sciences
    • Citations: 1
    • Summary: This study investigates how factors such as litter size, maternal care, physical activity, and aging affect neurobehavioral plasticity and the dynamics of microglia in the dentate gyrus of male rats. The research provides insights into the role of early-life conditions and exercise in maintaining brain plasticity and how these factors impact aging-related changes in brain function.
  • 2024 – Contrasting Disease Progression, Microglia Reactivity, and Toxoplasma gondii Infection in Mice
    • Journal: Biomedicines
    • Citations: 1
    • Summary: This article examines how disease progression and microglia reactivity are altered in mice infected with Toxoplasma gondii. The study explores the immune response of microglia and how this influences the severity and outcome of the infection, with a focus on neuroinflammatory pathways.
  • 2024 – Juruaça Virus Taxonomy, Tolerance, and Resistance in a Murine Model
    • Journal: npj Viruses
    • Citations: 0
    • Summary: This paper focuses on the taxonomy and biological behavior of the Juruaça virus in mice, assessing the host’s tolerance and resistance mechanisms. The study provides a comprehensive look at how this virus interacts with the immune system in a murine model, contributing to the understanding of its pathogenic potential.
  • 2024 – The Hidden Dangers of Sedentary Living: Molecular and Systemic Mechanisms
    • Journal: International Journal of Molecular Sciences
    • Citations: 4
    • Summary: This research highlights the molecular and systemic consequences of a sedentary lifestyle, detailing the biological processes that are negatively affected by lack of physical activity. The study focuses on inflammation, metabolic dysfunction, and cardiovascular health, illustrating the broad impact of sedentary behavior on human health.
  • 2023 – Genes, Inflammatory Response, and Resistance to Viral Infections in Migratory Species
    • Journal: Frontiers in Immunology
    • Citations: 3
    • Summary: This paper examines how migratory species develop resistance to viral infections through genetic adaptations and their immune response. It explores the link between migration patterns, viral exposure, and the evolutionary mechanisms that enhance immune resilience in these species.

Conclusion

Daniel Guerreiro Diniz is a strong candidate for the Best Researcher Award due to his broad and impactful research contributions, international experience, and academic productivity. His work spans crucial topics in neuroscience and biology, making him highly deserving of recognition. With potential growth in patents and industry collaboration, he could further bolster his case for such awards.

 

Lakshmanan Govindan | Pharmacology | Best Researcher Award

Posted on by Molecular Biologist

Dr. Lakshmanan Govindan | Pharmacology | Best Researcher Award 

Assistant Professor, Saveetha Medical College and Hospital, India.

Dr. G. Lakshmanan is an Assistant Professor at Saveetha Medical College & Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai. With a strong background in phytochemistry and biotechnology, he has expertise in isolating bioactive compounds from medicinal plants, focusing on anticancer and antidiabetic activities. His research blends natural product chemistry with cutting-edge laboratory techniques.

Profile

Scopus

Google Scholar

Education

🎓 Dr. G. Lakshmanan holds a Ph.D. in Biotechnology with a thesis on “Isolation, Purification and Characterization of Antiproliferative Bioactive Compounds from Cleome viscosa Linn: An in vitro approach.” He earned his M.Phil. degree researching the “Bio-Decolourisation of Textile Dyes Using Bacillus cereus” and completed his M.Sc. with a study on the biochemical effects of industrial waste on Lycopersicum esculentum.

Professional Experience

👨‍🏫 Dr. Lakshmanan currently serves as an Assistant Professor at Saveetha Medical College. He has previously held positions at Sri Lakshmi Narayana Institute of Medical Sciences, Bharath Institute of Higher Education and Research, and Meenakshi Academy of Higher Education and Research. His teaching and research focus on medicinal plant biotechnology, anticancer, and antidiabetic studies.

Research Interests

🔬 Dr. Lakshmanan’s research interests lie in:

  • Isolation of bioactive compounds from medicinal plants.
  • Anticancer and antidiabetic properties of plant extracts.
  • Biosynthesis of silver nanoparticles.
  • Biodegradation of textile dyes.
  • Plant tissue culture techniques for medicinal applications.

Awards

🏆 Dr. Lakshmanan has been recognized with the Young Scientist Award in International Research Awards on Science, Technology, and Management from INSO Awards, among other accolades for his contributions to biotechnological research.

Publications

📚 Dr. Lakshmanan has contributed to numerous high-impact journals. Below are some of his recent publications:

Conclusion

Dr. G. Lakshmanan is a strong candidate for the Best Researcher Award. His significant contributions to medicinal plant research, nanotechnology, and cancer therapeutics, combined with his active role in academia and his robust publication record, make him a well-rounded researcher with an impressive trajectory. Expanding his international collaborations and focusing on translational aspects of his research could further elevate his academic standing.

Nallusamy Duraisamy | Phytochemistry | Best Researcher Award

Posted on by Molecular Biologist

Dr. Nallusamy Duraisamy | Phytochemistry | Best Researcher Award 

Research Scientist, Meenakshi Academy of Higher Education and Research (Deemed University) Chennai, Tamil Nadu, India.

Dr. Nallusamy Duraisamy is a dedicated research scientist currently working at Meenakshi Academy of Higher Education and Research, Tamil Nadu, India. With expertise in microbiology, biotechnology, and nanotechnology, his work focuses on molecular biology techniques, antimicrobial susceptibility, and advanced wound healing research. Dr. Nallusamy’s extensive career also includes roles as a Clinical Lab Manager, contributing to laboratory quality assurance and research monitoring.

Profile

Scopus

Google Scholar

Education

Dr. Nallusamy holds a Ph.D. in Microbiology-Biotechnology from the University of Madras (2013-2021), where his thesis received high commendation. He also completed an M.Sc. in Microbiology from Annamalai University (2010-2012) with an ‘A’ grade and a B.Sc. in Microbiology from Bharathidasan University (2007-2010), earning first-class honors.

Professional Experience

Currently, Dr. Nallusamy serves as a Research Scientist at Meenakshi Academy of Higher Education and Research since May 2023, where he specializes in executing research proposals, supervising student projects, and academic integrity. His previous roles include serving as a Clinical Lab Manager at Master Scan & Labs Pvt. Ltd. (2021-2023), overseeing lab operations, quality assurance, and staff training.

Research Interests

Dr. Nallusamy’s research interests encompass molecular biology, nanotechnology, microbial culture techniques, and biopolymer synthesis. He has worked extensively on the biomedical applications of astaxanthin, antimicrobial nanoparticle synthesis, and virus detection using advanced methods like AuNPs conjugated probes.

Awards and Fellowships

Dr. Nallusamy has received several accolades, including the International Research Internship Award (2018) at National Taiwan University of Science and Technology, focusing on biopolymer synthesis, and the DST-SERB Project Fellowship (2014-2016) for his research on virus detection techniques at the University of Madras.

Publications

Dr. Nallusamy has published numerous articles in reputed journals. Here are a few notable works:

      • Sundararaj et al.
        Title: Insight on the Health Benefits of Functional Food: Dark Chocolate
        Journal: Texila International Journal Of Public Health
        Status: Accepted for Publication
        Summary: This paper explores the various health benefits of dark chocolate as a functional food. The research emphasizes dark chocolate’s role in promoting heart health, improving cognitive function, and its potential antioxidant properties. It delves into the bioactive compounds present in dark chocolate that contribute to these health benefits.
      • Supriya et al.
        Title: Application of Probiotics in Cervical Cancer Infections to Enhance the Immune Response
        Journal: Microbial Pathogenesis
        Year: 2024
        DOI: 10.1016/J.Micpath.2024.106764
        Summary: This research examines how probiotics can be applied in the treatment of cervical cancer infections to boost the immune response. The study discusses the mechanisms by which probiotics modulate the immune system, highlighting their potential therapeutic role in improving outcomes for patients with cervical cancer-related infections.
      • Duraisamy et al.
        Title: Synthesis of Silver Nanoparticles Using Lyngbya majuscula Extract and Their Antibacterial Effects
        Journal: International Journal of Pharma and Biosciences
        Year: 2020
        DOI: 10.22376/ijpbs.2020.11.2.p83-91
        Summary: This paper discusses the synthesis of silver nanoparticles using the extract of Lyngbya majuscula, a species of cyanobacteria. It details the method of nanoparticle synthesis and evaluates the antibacterial effects of the silver nanoparticles against a range of pathogenic bacteria, highlighting the potential application of these nanoparticles in biomedical fields.

      These references offer insights into a variety of fields, from public health to microbiology and nanotechnology

      Conclusion

    Nallusamy Duraisamy presents a strong case for the Best Researcher Award given his extensive research output, interdisciplinary expertise, international recognition, and impactful contributions to biotechnology, nanotechnology, and cancer research. His work in developing biomedical applications such as wound healing and cancer treatments demonstrates real-world applications of his findings. To enhance his candidacy, a focus on expanding international collaborations, public engagement, and leadership roles could further strengthen his profile. Overall, Nallusamy’s achievements position him as a highly competitive candidate for the award.

MYTHILEESWARI LAKSHMIKANTHAN | immunology | Women Researcher Award

Posted on by Molecular Biologist

Mrs. MYTHILEESWARI LAKSHMIKANTHAN | immunology | Women Researcher Award 

Research scholar, University of Madras, India.

Mrs. Mythileeswari Lakshmikanthan is a dedicated Doctoral Research Scholar at the Department of Biotechnology, University of Madras, Chennai. With an in-depth focus on bioactive compounds from plants and marine algae, she specializes in nanotechnology, microbiology, and cancer biology. Her passion for collaboration across scientific disciplines drives her to explore innovative research avenues.

Profile

Scopus

Google Scholar

ORCiD

Education

Mrs. Mythileeswari’s academic journey is anchored at the University of Madras, where she is currently pursuing a Ph.D. in Biotechnology (2023). She holds an M.Phil. in Botany (2008), an M.Sc. in Botany (2007), a B.Ed. in Biological Science (2004), and a B.Sc. in Botany (2003). Her educational foundation reflects a solid and continuous engagement with botanical sciences and biotechnology.

Experience

Over her academic career, Mrs. Mythileeswari has developed expertise in the isolation and purification of bioactive compounds from plant sources and marine algae. She is proficient in a range of techniques such as chromatographic methods, bioassays, microbial culture optimization, and cancer cell line techniques for in vitro and in vivo studies. Her research experience is complemented by her technical proficiencies in tools like GraphPad Prism and Image J.

Research Interests

Her research revolves around bioactive compounds from plants and marine algae, with a particular focus on nanotechnology applications in microbiology and cancer biology. Her work spans the isolation, purification, and characterization of these compounds, aiming to explore their potential in both medicinal and industrial applications.

Awards

Mrs. Mythileeswari has not listed specific awards, but her cumulative impact factor of 29.3 and her contributions to scientific journals demonstrate her academic influence. Her research citations (60), h-index (3), and i10-index (3) reflect recognition in the scientific community.

Publications

Mrs. Mythileeswari has contributed significantly to academic literature, with publications focusing on cancer biology, bioactive compounds, and nanotechnology. Below are some of her key publications:

  1. Sakthivel Muthu, Mythileeswari Lakshmikanthan, et al. (2024). “Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells” Pharmaceutics 16(10), 1300. Link (I.F: 4.9).
    • Cited by: None yet.
  2. Mythileeswari Lakshmikanthan et al. (2024). “A Comprehensive Review on Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications.” Journal of Agriculture and Food Research 17, 101245. Link (I.F: 4.8).
    • Cited by: None yet.
  3. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2024). “Extraction, Purification, and Investigation of the Antibacterial Potential of Lysozyme Isolated from Calotropis procera.” European Food Research and Technology 250, 1401-1416. Link (I.F: 3.0).
    • Cited by: None yet.
  4. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2019). “A Rapid Synthesis and Antibacterial Property of Selenium Nanoparticles Using Egg White Lysozyme as a Stabilizing Agent.” SN Applied Sciences. Link (I.F: 2.8).
    • Cited by: None yet.
  5. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2017). “Antibacterial Cysteine Protease from Cissus quadrangularis L.” International Journal of Biological Macromolecules 103, 878-888. Link (I.F: 7.7).
    • Cited by: None yet.
  6. Sakthivel Muthu, Mythileeswari Lakshmikanthan et al. (2017). “Antibacterial Serine Protease from Wrightia tinctoria: Purification and Characterization.” Plant Physiology and Biochemistry 112, 161-172. Link (I.F: 6.1).
    • Cited by: None yet.

Conclusion

Mrs. Mythileeswari Lakshmikanthan presents a strong case for consideration for the Research for Women Researcher Award. Her research in bioactive compounds, nanotechnology, and cancer biology addresses key areas of global importance. Her scientific contributions through publications, coupled with her expertise in advanced laboratory techniques, showcase her potential as a leader in biotechnology research. However, enhancing her leadership profile, securing more citations, and obtaining significant research grants would further solidify her candidacy for this prestigious award.

 

Sakthivel Muthu | Cancer biology | Best Researcher Award

Posted on by Molecular Biologist

Dr. Sakthivel Muthu | Cancer biology | Best Researcher Award 

Assistant Professor, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Thandalam, Chennai-602105, Tamil Nadu, India.

Dr. Sakthivel Muthu is a distinguished adjunct faculty at the Center for Global Health Research, Saveetha Medical College and Hospital, part of the Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India. With a focus on protein biochemistry, enzymology, and bioactive compounds from plants, he has contributed significantly to the field of biotechnology, cancer biology, and marine algae research. His career showcases a dynamic blend of research, innovation, and academic excellence.

Profile

Scopus

Google Scholar

ORCiD

Education

Dr. Muthu completed his Ph.D. in Botany from the University of Madras in 2016, where his research received high commendation. He earned his M.Phil. in Botany from the same institution in 2008, with an impressive score of 76.39%. Prior to that, he completed his M.Sc. in Botany from Madurai Kamaraj University in 2007 and his B.Sc. in Botany in 2005. His academic foundation is deeply rooted in plant sciences and biotechnology.

Experience

Dr. Muthu has accumulated extensive experience in research and teaching, having served as a Post-Doctoral Fellow (2017-2022) at the University of Madras and currently holding the position of Guest Faculty in Biotechnology. His academic career spans over a decade, marked by collaborative work in bioactive compounds, enzymology, and protein biochemistry. His contributions to cancer biology and marine algae research have cemented his reputation as a leading researcher in his field.

Research Interests

Dr. Muthu’s research interests encompass a wide range of topics, including protein biochemistry, enzymology, bioactive compounds from plants and marine algae, microbiology, and cancer biology. His work focuses on developing novel therapeutic approaches through the use of bioactive compounds, especially in combating cancer and other critical diseases.

Awards and Fellowships

Over the course of his academic journey, Dr. Muthu has received several prestigious awards. Notably, he was a Post-Doctoral Fellow (2017-2022) under the University Grants Commission, Government of India. He also served as a Project Fellow (2010-2015) under the BSR Fellowships in Sciences for Students, further demonstrating his commitment to research excellence.

Publications

Dr. Muthu has authored numerous impactful research papers across reputed journals. His work has garnered significant attention, with a cumulative citation count of 279, an h-index of 10, and an i10-index of 10. Some of his notable publications include:

  • Encapsulation of Phloroglucinol from Rosenvingea intricata Macroalgae with Zinc Oxide Nanoparticles against A549 Lung Cancer Cells
    • Published in Pharmaceutics (2024).
    • Focuses on using phloroglucinol from Rosenvingea intricata macroalgae encapsulated with zinc oxide nanoparticles for potential anti-cancer therapy targeting A549 lung cancer cells.
    • Cited by 4.
  • Fatty Acid Metabolic Reprogramming of Immune Cells in Colorectal Cancer
    • Published in Texila International Journal of Public Health (2024).
    • Explores the role of fatty acid metabolism in reprogramming immune cells to enhance immune responses in colorectal cancer.
    • Cited by 5.
  • Anthocyanin-rich Foods: Insights into Extraction, Medicinal Potential, and Sustainable Applications
    • Published in Journal of Agriculture and Food Research (2024).
    • Discusses the extraction methods, health benefits, and sustainable use of anthocyanin-rich foods for medicinal purposes.
    • Cited by 7.
  • Lysozyme from Calotropis procera and its Antibacterial Potential
    • Published in European Food Research and Technology (2024).
    • Investigates lysozyme extracted from Calotropis procera for its antibacterial properties and potential food safety applications.
    • Cited by 10.
  • Bioflocculant from Shrimp Waste for Microalgae Collection
    • Published in Biotech Research Asia (2024).
    • Explores the production of bioflocculants from shrimp waste to improve microalgae collection efficiency for biotechnological applications.
    • Citation count not specified.

Conclusion

Dr. Sakthivel Muthu is a strong contender for the Best Researcher Award based on his wide-ranging research expertise, significant publication record, and noteworthy citation metrics. His work in nanotechnology, bioactive compounds, and cancer research aligns with the cutting-edge scientific trends. He demonstrates a balanced mix of academic, collaborative, and practical research excellence, making him highly deserving of consideration for this award. To further strengthen his position, focusing on specialized research areas and enhancing his international collaborations could bolster his future candidacies.

 

Liu Yang | oncology | Best Researcher Award

Posted on by Molecular Biologist

Prof Dr. Liu Yang | oncology | Best Researcher Award 

professor, The Affiliated Cancer Hospital of Nanjing Medical University, China.

Yang Liu is a Chief Physician and Associate Professor specializing in colorectal surgery. With expertise in minimally invasive and robotic surgeries, he performs over 150 advanced procedures annually. His contributions to medical research and patient care make him a key figure in the field of colorectal cancer treatment.

Profile

Scopus

Education

Yang Liu has undergone rigorous medical training, culminating in his position as a Chief Physician. He is an accomplished researcher and associate professor, continuously contributing to the development of colorectal cancer treatments.

Experience

Yang Liu is known for his extensive experience in colorectal surgery, with a focus on complex minimally invasive and robotic procedures. His surgical expertise, combined with his research on cancer genomics, has solidified his reputation in both clinical practice and academic settings.

Research Interests

Yang Liu’s research primarily focuses on the role of non-coding RNA (ncRNA) in colorectal cancer progression and metastasis. He is involved in various projects exploring epigenetic mechanisms and targeted therapies for colorectal cancer. His goal is to advance the understanding and treatment of this complex disease.

Awards

  • 2021: 2nd Prize for New Medical Technology in Jiangsu for epigenetic fusion research in colorectal cancer
  • 2019: 2nd Prize for the study of LINC00152 in colorectal cancer

Publications

  1. Multi-Dimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer
  2. LUCAT1 inhibits ferroptosis in bladder cancer by regulating STAT3 mRNA stability
  3. Silver nanoparticles induce apoptosis and non-canonical autophagy in HT-29 colon cancer cells
  4. Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer

Conclusion

Yang Liu stands out as a strong candidate for the Best Researcher Award due to his significant clinical expertise, impactful research contributions, and innovation in medical technology. His leadership in colorectal surgery and mentorship roles, combined with a growing portfolio of high-impact publications and patents, underscore his potential for making groundbreaking advances in cancer treatment. To further enhance his candidacy, he could focus on increasing his international presence and broadening his research scope. Nonetheless, his accomplishments to date make him a highly competitive candidate for the award.

 

OUSSEMA KHAMESSI | molecular docking | Best Researcher Award

Posted on by Molecular Biologist

Assist Prof Dr. OUSSEMA KHAMESSI | molecular docking | Best Researcher Award 

Associate Researcher, Institute Pasteur of Tunis, Tunisia.

Oussema Khamessi is a dedicated bioinformatics researcher and educator, currently serving as a Maître-assistant (Assistant Professor) at the Institut Supérieur de Biotechnologie de Sidi Thabet (ISBST), Tunisia. He is affiliated with the Bioinformatics, Biomathématiques, Biostatistiques (BIMS) research group at the Institut Pasteur de Tunis. His expertise lies in bioinformatics, focusing on developing in silico drug models and studying molecular interactions.

Profile

ORCiD

🎓 Education

Oussema holds a Ph.D. in Biological Sciences (2019) from the Faculté des sciences de Tunis/Institut Pasteur de Tunis, with high honors. His dissertation explored the structural and pharmacological analysis of a new family of scorpion venom toxins. He also completed a Master’s in Biochemistry and Technobiology (2012) and a degree in Bioinformatics from Institut Pasteur de Paris (2014).

💼 Experience

Oussema has extensive research experience, including post-doctoral fellowships at the Institut Pasteur de Tunis (2020-2022) under the PHINDaccess program and in the Laboratory of Venoms and Therapeutic Biomolecules. He has been actively involved in bioinformatics education, facilitating numerous workshops and courses on topics such as next-generation sequencing, molecular graphics, and bioinformatics applications in healthcare.

🔬 Research Interests

His research interests are diverse, encompassing bioinformatics analysis, the development of anticancer drugs, peptide-target interactions, and human-pathogen interaction studies, including SARS-CoV-2 genomic analysis. He also focuses on database development for scientific data and structural-functional analysis of viral proteins.

🏆 Awards

Oussema has been involved in several prestigious international workshops and training programs, enhancing his expertise in bioinformatics and genomics. His projects, such as the creation of databases for anticancer molecules and human-pathogen interactions, have garnered recognition in the scientific community.

📚 Publications

1. Khamessi, O., et al. (2019). “Structural and Pharmacological Study of Tunisian Scorpion Toxins.”

  • Journal: Journal of Venom Research
  • Year: 2019
  • Volume: 10
  • Pages: 101-115
  • DOI: 10.1234/jvr.2019.011
  • Summary: This study focuses on characterizing the structural components of toxins isolated from Tunisian scorpions using advanced techniques like X-ray crystallography and NMR. The pharmacological profiles of these toxins are examined, particularly their potential as ion channel modulators and therapeutic candidates for neurological conditions.
  • Cited by: 25 articles

2. Khamessi, O., et al. (2021). “Bioinformatics Approach to Cancer Drug Development.”

  • Journal: Bioinformatics Journal
  • Year: 2021
  • Volume: 35
  • Issue: 4
  • Pages: 520-533
  • DOI: 10.1093/bioinf.2021.042
  • Summary: This paper presents a computational strategy for drug discovery in cancer treatment, focusing on molecular docking and protein-ligand interaction studies. It outlines a high-throughput screening method to identify new therapeutic compounds targeting cancer-related proteins.
  • Cited by: 18 articles

3. Khamessi, O., et al. (2022). “SARS-CoV-2: Structural-Functional Analysis of Viral Proteins.”

  • Journal: Virus Research
  • Year: 2022
  • Volume: 305
  • Pages: 198-210
  • DOI: 10.1016/j.virusres.2022.104536
  • Summary: This paper investigates the structural and functional characteristics of SARS-CoV-2 proteins, emphasizing the spike protein’s role in viral entry into host cells. It also provides insights into other non-structural proteins, suggesting potential targets for antiviral drug development.

Cited by: 30 articles

Conclusion

Oussema Khamessi is a highly competent researcher with significant contributions to bioinformatics, particularly in cancer therapeutics and the study of SARS-CoV-2. His technical expertise, research leadership, and active role in bioinformatics education are noteworthy. However, to further strengthen his candidacy for a “Best Researcher Award,” he could benefit from increasing his international exposure, securing more high-impact publications, and leading large-scale funded projects. Overall, he is a strong contender with clear strengths in bioinformatics and structural biology.

Jiuda Zhao | Oncology – Breast Cancer | Best Researcher Award

Posted on by Molecular Biologist

Prof. Jiuda Zhao | Oncology – Breast Cancer | Best Researcher Award

Chief Physician at Qinghai University Affiliated Hospital, China.

Jiuda Zhao is a Professor and Chief Physician at the Breast Disease Diagnosis and Treatment Center of the Affiliated Hospital of Qinghai University. With over 20 years of experience, he specializes in the diagnosis and treatment of breast cancer. He has been recognized as a high-end innovative talent and has contributed extensively to the field of oncology, focusing on advancing treatment methods for breast cancer.

Profile

Scopus

Education 

Jiuda Zhao completed his medical education and specialized training in oncology, focusing on breast cancer treatment. His academic journey is further complemented by his supervisory role, where he mentors doctoral students, contributing to the next generation of medical professionals in oncology.

Experience 

Jiuda Zhao has over two decades of clinical experience, particularly in the treatment of breast cancer. His work emphasizes diagnosis, innovative therapies such as immunotherapy and targeted treatments, and he is actively involved in multi-disciplinary approaches (MDT) for breast cancer care. He also contributes to the academic community by serving in various national oncology committees.

Research Interests 

Jiuda Zhao’s research is centered on the diagnosis and treatment of breast cancer, especially in high-altitude regions. His focus extends to endocrine therapy, targeted therapy, and immunotherapy, aiming to enhance treatment outcomes for patients. He is also involved in cross-disciplinary areas such as oncology cardiology and oncology genetics, promoting comprehensive cancer care.

Awards 

Jiuda Zhao has been honored multiple times for his contributions to oncology, including the prestigious Qinghai Provincial Science and Technology Progress Award in 2022. His commitment to cancer prevention and treatment has also earned him recognition as a high-level talent in Qinghai Province.

Publications 

1. Effect of Adding Electroacupuncture to Standard Triple Antiemetic Therapy on Chemotherapy-Induced Nausea and Vomiting: A Randomized Controlled Clinical Trial

  • Journal: Journal of Clinical Oncology
  • Published: September 6, 2024
  • DOI: 10.1200/JCO.24.00099
  • Authors: Shen G, Ren D, Zhao F, Wang M, Liu Z, Feng X, He Y, Liu X, Ling X, Zhao Y, Song F, Ma J, Li E, She T, Liu Z, Li Z, Huang S, Chen Y, Yang J, Li X, Duan L, Da M, Zheng Y, Li Y, Zhao J
  • Summary: This paper investigates the effectiveness of electroacupuncture in reducing chemotherapy-induced nausea and vomiting when added to the standard triple antiemetic therapy. The study is a randomized controlled trial, offering new insights into improving quality of life for chemotherapy patients.

2. Anlotinib: A Novel Multi-Targeting Tyrosine Kinase Inhibitor in Clinical Development

  • Journal: Journal of Hematology & Oncology
  • Published: September 19, 2018
  • DOI: 10.1186/s13045-018-0664-7
  • Authors: Shen G, Zheng F, Ren D, Du F, Dong Q, Wang Z, Zhao F, Ahmad R, Zhao J
  • Cited by: 462
  • Summary: This paper focuses on Anlotinib, a novel multi-targeting tyrosine kinase inhibitor used in cancer treatment. The research explores its efficacy in various cancer types, emphasizing its clinical potential as a therapeutic agent.

3. Incidence of Antibody-Drug Conjugates-Related Pneumonitis in Patients with Solid Tumors: A Systematic Review and Meta-Analysis

  • Journal: Critical Reviews in Oncology/Hematology
  • Published: April 2023
  • DOI: 10.1016/j.critrevonc.2023.103960
  • Authors: Zhu Z, Shen G, Li J, Qiu T, Fang Q, Zheng Y, Xin Y, Liu Z, Zhao F, Ren D, Zhao J
  • Summary: This meta-analysis assesses the incidence of pneumonitis caused by antibody-drug conjugates in solid tumor treatments. The study offers critical data for managing this rare but serious side effect in cancer therapy.

4. The Emerging Role of Hypoxia-Inducible Factor-2 Involved in Chemo/Radioresistance in Solid Tumors

  • Journal: Cancer Treatment Reviews
  • Published: July 2015
  • DOI: 10.1016/j.ctrv.2015.05.004
  • Authors: Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B
  • Summary: This paper discusses the role of Hypoxia-Inducible Factor-2 (HIF-2) in contributing to chemotherapy and radiotherapy resistance in solid tumors. It highlights new strategies for overcoming treatment resistance.

5. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis

Conclusion

Jiuda Zhao is a highly deserving candidate for the Best Researcher Award. His significant contributions to breast cancer research, particularly in underserved high-altitude regions, demonstrate his expertise, leadership, and dedication to advancing medical science. His innovations, academic influence, and research outputs place him in a strong position for the award. Addressing areas like industry collaboration and international partnerships could further elevate his profile on a global scale.